XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 347,487 $ 605,378
Marketable securities 304,606 172,266
Accounts receivable, net 240,584 203,623
Inventory 128,534 127,475
Prepaid expenses and other current assets 99,059 85,627
Total current assets 1,120,270 1,194,369
Long-term Assets:    
Property, plant and equipment, net 702,041 698,354
Operating lease right-of-use assets 142,017 143,708
Goodwill 2,367,052 2,367,120
Intangible assets, net 1,866,856 1,890,396
Other long-term assets, net 178,085 177,387
Total assets 6,376,321 6,471,334
Current liabilities:    
Accounts payable 60,498 78,816
Accrued liabilities 265,121 341,683
Operating lease liabilities, current portion 27,225 29,379
Convertible Notes Payable, Current 248,810 0
Loans Payable, Current 50,000 50,000
Other current liabilities 33,455 14,823
Total current liabilities 685,109 514,701
Long-term liabilities:    
Convertible notes, net, less current portion 2,066,805 2,314,276
Other long-term liabilities 329,384 335,982
Operating lease liabilities, less current portion 162,405 161,070
Total liabilities 3,243,703 3,326,029
Commitments and contingencies (Note 14)
Stockholders’ equity:    
Preferred stock, $0.01 par value Authorized—5,000,000; shares issued and outstanding—no shares at March 31, 2024 and December 31, 2023 0 0
Common stock, $0.01 par value Authorized—400,000,000; shares issued and outstanding—183,845,188 and 181,364,180 shares at March 31, 2024 and December 31, 2023 1,839 1,815
Additional paid-in capital 6,710,681 6,611,237
Accumulated other comprehensive income (loss) (499) 1,428
Accumulated deficit (3,579,403) (3,469,175)
Total stockholders’ equity 3,132,618 3,145,305
Total liabilities and stockholders’ equity $ 6,376,321 $ 6,471,334